高级检索

中国和美国≥50岁人群虚弱状态变化与慢性肺部疾病发生风险关联性:基于CHARLS和HRS队列数据分析

Association between changes in frailty status and risk of developing chronic lung diseases in adults aged ≥ 50 years in China and the United States: an analysis based on data from the CHARLS and HRS cohorts

  • 摘要:
    目的 探讨中国和美国≥50岁人群虚弱状态变化与慢性肺部疾病(CLD)发生风险的关联性,为针对高危人群开展早期识别与干预措施提供参考依据。
    方法 基于2011—2018年中国健康与养老追踪调查(CHARLS)4轮调查的6 338名≥50岁人群数据和2006—2018年美国健康与退休研究(HRS)14轮调查的6 465名≥50岁人群数据。采用前瞻性队列研究并通过虚弱指数(FI)评估此2个队列中≥50岁人群的虚弱状态,将其分为强壮、较虚弱和虚弱,通过比较基线调查与第2次和最后1次调查的FI值来评估虚弱状态的变化;并采用多因素Cox比例风险回归模型分析其虚弱状态的变化与CLD发生风险的关联性。
    结果 CHARLS基线调查中虚弱者、较虚弱者和强壮者分别占11.2%(709/6338)、45.3%(2 871/6338)和43.5%(2 758/6338),随访中保持强壮者、稳定虚弱者、进展为比较虚弱/虚弱者和恢复为较虚弱/强壮者分别占19.8%(1 254/6338)、3.0%(192/6338)、20.3%(1 289/6338)和5.9%(371/6338);HRS基线调查中虚弱者、较虚弱者和强壮者分别占27.5%(1 778/6465)、46.7%(3018/6465)和25.8%(1 669/6465),随访中保持强壮者、稳定虚弱者、进展为比较虚弱/虚弱者和恢复为较虚弱/强壮者分别占9.1%(585/6465)、16.5%(1 064/6465)、15.6%(1 006/6465)和3.1%(202/6465)。CHARLS和HRS调查随访中保持强壮者、稳定虚弱者、进展为比较虚弱/虚弱者、恢复为较虚弱/强壮者CLD发生率分别为5.7%(71/1 254)和1.9%(11/585)、21.9%(42/192)和18.0%(191/1 064)、12.7%(164/1 289)和8.0%(80/1 006)、13.5%(50/371)和7.9%(16/202)。在调整性别、年龄、文化程度、婚姻状况、吸烟情况、饮酒情况、体力活动水平、体质指数、糖化血红蛋白、高密度脂蛋白胆固醇、血清胱抑素C和C反应蛋白等混杂因素后,多因素Cox比例风险回归分析结果显示,CHARLS和HRS调查中进展为比较虚弱/虚弱者CLD发生风险分别为保持强壮者的2.40倍(HR=2.40,95%CI=1.85~3.21)和3.87倍(HR=3.87,95%CI=2.06~7.29);恢复为较虚弱/强壮者CLD发生风险分别为稳定虚弱者的0.63倍(HR=0.63,95%CI=0.42~0.94)和0.41倍(HR=0.41,95%CI=0.27~0.63);分层分析结果显示,CHARLS和HRS队列中男性、女性、≤65岁、>65岁进展为比较虚弱/虚弱者CLD发生风险分别为保持强壮者的2.15倍(HR=2.15,95%CI=1.53~3.00)和2.57倍(HR=2.57,95%CI=1.14~5.80)、3.05倍(HR=3.05,95%CI=1.82~5.10)和5.88倍(HR=5.88,95%CI=2.10~16.42)、2.34倍(HR=2.34,95%CI=1.74~3.15)和3.26倍(HR=3.26,95%CI=1.58~6.74)、3.03倍(HR=3.03,95%CI=1.42~6.49)和5.65倍(HR=5.65,95%CI=1.36~23.42)。CHARLS和HRS队列中女性恢复为较虚弱/强壮者CLD发生风险分别为稳定虚弱者的0.58倍(HR=0.58,95%CI=0.34~0.93)和0.39倍(HR=0.39,95%CI=0.23~0.65);HRS队列中≤65岁和>65岁恢复为较虚弱/强壮者CLD发生风险分别为稳定虚弱者的0.45倍(HR=0.45,95%CI=0.26~0.80)和0.35倍(HR=0.35,95%CI=0.18~0.70)。
    结论 中国和美国的关联趋势一致,虚弱状态变化是CLD发生的独立影响因素。

     

    Abstract:
    Objective To investigate the association between changes in frailty status and the risk of developing chronic lung diseases (CLD) among individuals aged ≥ 50 years in China and the United States, providing evidence to support early identification and targeted interventions for high-risk populations.
    Methods Data of 6 338 individuals aged ≥ 50 years from four waves of the China Health and Retirement Longitudinal Study (CHARLS) conducted between 2011 and 2018 and 6 465 individuals aged ≥ 50 years from fourteen waves of the U.S. Health and Retirement Study (HRS) conducted between 2006 and 2018 were collected. A prospective cohort design was employed to assess frailty status in both cohorts based on the frailty index (FI). Participants were classified into three categories–robust, pre-frail, and frail participants–based on their FI values. Changes in frailty status were evaluated by comparing FI values at baseline and at two subsequent assessments–the second and the final survey waves. Multivariable Cox proportional hazards regression models were adopted to examine the association between changes in frailty status and the incidence risk of CLD.
    Results In the CHARLS baseline survey, frail, pre-frail, and robust participants accounted for 11.2% (709/6 338), 45.3% (2 871/6 338), and 43.5% (2 758/6 338), respectively. During follow-up, participants who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness constituted 19.8% (1 254/6 338), 3.0% (192/6 338), 20.3% (1 289/6 338), and 5.9% (371/6 338), respectively. In the HRS baseline survey, frail, pre-frail, and robust participants accounted for 27.5% (1 778/6 465), 46.7% (3 018/6 465), and 25.8% (1 669/6 465), respectively. During follow-up, participants who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness constituted 9.1% (585/6 465), 16.5% (1 064/6 465), 15.6% (1 006/6 465), and 3.1% (202/6 465), respectively. The CLD incidence among those who remained robust, maintained frailty, progressed to pre-frailty or frailty, and recovered to pre-frailty or robustness was 5.7% (71/1 254), 21.9% (42/192), 12.7% (164/1 289), and 13.5% (50/371), respectively, in CHARLS and 1.9% (11/585), 18.0% (191/1 064), 8.0% (80/1 006), and 7.9% (16/202), respectively, in HRS. After adjusting for potential confounders including sex, age, educational attainment, marital status, smoking status, alcohol consumption, physical activity level, body mass index, glycated hemoglobin, high-density lipoprotein cholesterol, serum cystatin C, and C-reactive protein, multivariable Cox proportional hazards regression analysis revealed that in CHARLS and HRS, the hazard ratios (HRs) for CLD incidence among participants who progressed to pre-frailty or frailty were 2.40 (95%CI: 1.85–3.21) and 3.87 (95%CI: 2.06–7.29), respectively, relative to those who remained robust. Among participants who recovered to pre-frailty or robustness, the HRs for CLD incidence were 0.63 (95%CI: 0.42–0.94) in CHARLS and 0.41 (95%CI: 0.27–0.63) in HRS, relative to maintained frailty. Stratified analyses showed that the HRs for CLD incidence among males, females, participants aged ≤ 65 years, and participants aged > 65 years who progressed to pre-frailty or frailty were 2.15 (95%CI: 1.53–3.00), 3.05 (95%CI: 1.82–5.10), 2.34 (95%CI: 1.74–3.15), and 3.03 (95%CI: 1.42–6.49), respectively, in CHARLS and 2.57 (95%CI: 1.14–5.80), 5.88 (95%CI: 2.10–16.42), 3.26 (95%CI: 1.58–6.74), and 5.65 (95%CI: 1.36–23.42), respectively, in HRS. Furthermore, in CHARLS and HRS, the HRs for CLD incidence among females who recovered to pre-frailty or robustness were 0.58 (95%CI: 0.34–0.93) and 0.39 (95%CI: 0.23–0.65), respectively, relative to those who maintained frailty. In HRS, the HRs for CLD incidence among participants aged ≤ 65 years and > 65 years who recovered to pre-frailty or robustness were 0.45 (95%CI: 0.26–0.80) and 0.35 (95%CI: 0.18–0.70), respectively, relative to those who maintained frailty.
    Conclusions The trend of association between China and the United States is consistent, and changes in frailty status are an independent risk factor for the development of CLD.

     

/

返回文章
返回